Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

New book brings the latest advances in gastroenterology and hepatology

Knowledge in medicine is a very dynamic process due to the continuing progress in this field. New developments influence research, but also the clinical practice. Hence the continuous need for improvement in the field in which we work is required.

29 May 2021

Melatonin prevents kidney damage caused by metabolic complications of obesity

Scientists from the University of Granada (UGR), the Hospital Universitario La Paz (Madrid), and the University of Texas (USA) have taken an important step in the fight against kidney damage and its progression towards kidney failure, which is closely related to diabesity (obesity and its type 2 diabetes) and its complications.

27 May 2021

Researchers investigate link between the liver’s immune system composition and NASH pathology

Our livers work hard to perform an entire range of activities: helping us digest food, maintaining body temperature and serving as an important checkpoint of the immune system for everything that we eat.

24 May 2021

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

A new multi-institution study led by a team of researchers at the David Geffen School of Medicine demonstrated that blocking a protein called ABCB10 in liver cells protects against high blood sugar and fatty liver disease in obese mice.

20 May 2021

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Owlstone Medical today announced agreements with Functional Gut Clinic ("FGC") and Functional Gut Diagnostics (“FGD”).

From Owlstone Medical Ltd 18 May 2021

A potential treatment to prevent obesity-related liver damage

One of the especially dangerous health risks of being extremely overweight occurs when an obese person begins to accumulate fat in their liver.

18 May 2021

Survey: 40% of people with liver disease have been worried about mental health impact of the pandemic

A survey by the British Liver Trust in March 2021 has revealed that 40% of people with liver disease have been worried about their mental health during the pandemic.

17 May 2021

UCL scientists identify new immunotherapy to combat hepatitis B virus

Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.

14 May 2021

A look at how coronavirus disease (COVID-19) affects Parkinson's

Earlier, herpes simplex virus (HSV), influenza virus A, measles virus, cytomegalovirus (CMV), and mumps virus have all been associated with after-effects of the virus that includes Parkinson's disease (PD). This list may now include SARS-CoV-2.

14 May 2021

New insights on how hospitalized patients develop liver injury from taking different drugs

A new study published in the British Journal of Clinical Pharmacology provides insights on how common hospitalized patients develop liver injury from taking different medications.

5 May 2021

Stomach-specific protein plays a key role in the progression of obesity

Scientists believe a stomach-specific protein plays a major role in the progression of obesity, according to new research in Scientific Reports.

4 May 2021

New study launched to more accurately diagnose early hepatocellular carcinoma

A first of its kind cohort study on patients at high risk of developing primary liver cancer also known as hepatocellular carcinoma (HCC), has been launched to diagnose HCC more accurately at an earlier stage and to predict an individual's likelihood of developing the cancer.

3 May 2021

Most long COVID-19 sequelae affect people under 65, finds study

A new study, released as a preprint on the medRxiv* server, discusses the typical symptoms and signs of this syndrome, with the intention of improving the specificity of detection and reporting.

3 May 2021

New approach could revolutionize the treatment of liver diseases

Researchers from Niigata University , the University of Tokyo, Osaka University and Tokyo Medical University, Japan have developed a new approach that could revolutionize the treatment, prevention, and possibly reversal of the damages caused by liver diseases.

3 May 2021

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH). PoPH occurs in approximately 15% of patients with PAH, and is reportedly found in 2-6% of patients with portal hypertension and 1-2% of patients with liver cirrhosis according to studies from Europe and America.

27 Apr 2021

Liver Disease News and Research

Further Reading

New book brings the latest advances in gastroenterology and hepatology

Melatonin prevents kidney damage caused by metabolic complications of obesity

Researchers investigate link between the liver’s immune system composition and NASH pathology

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

A potential treatment to prevent obesity-related liver damage

Survey: 40% of people with liver disease have been worried about mental health impact of the pandemic

UCL scientists identify new immunotherapy to combat hepatitis B virus

A look at how coronavirus disease (COVID-19) affects Parkinson's

New insights on how hospitalized patients develop liver injury from taking different drugs

Stomach-specific protein plays a key role in the progression of obesity

New study launched to more accurately diagnose early hepatocellular carcinoma

Most long COVID-19 sequelae affect people under 65, finds study

New approach could revolutionize the treatment of liver diseases

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Experimental drug reverses key symptoms of Alzheimer's disease in mice

Researchers aim to better understand clinical features associated with COVID-19 mortality

Probiotic L. acidophilus can effectively treat intestinal inflammation, research shows

Topical drug regenerates, restores function of erectile nerves damaged by radical prostatectomy

Cocoa consumption improves health of obese mice with liver disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News